The ABIO chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ABIO chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The ABIO stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
View ABIO Detailed Price Forecast - CNN Money | View ABIO Detailed Summary - Google Finance | ||
View ABIO Detailed Summary - Yahoo! Finance | View ABIO Stock Research & Analysis - Zacks.com |
View ABIO Trends & Analysis - Trade-Ideas | View ABIO Major Holders - Barrons | ||
View ABIO Call Transcripts - NASDAQ | View ABIO Breaking News & Analysis - Seeking Alpha | ||
View ABIO Annual Report - CompanySpotlight.com | View ABIO OTC Short Report - OTCShortReport.com | ||
View ABIO Fundamentals - TradeKing | View ABIO SEC Filings - Bar Chart | ||
View Historical Prices for ABIO - The WSJ | View Performance/Total Return for ABIO - Morningstar | ||
View the Analyst Estimates for ABIO - MarketWatch | View the Earnings History for ABIO - CNBC | ||
View the ABIO Earnings - StockMarketWatch | View ABIO Buy or Sell Recommendations - MacroAxis | ||
View the ABIO Bullish Patterns - American Bulls | View ABIO Short Pain Metrics - ShortPainBot.com |
View ABIO Stock Mentions - StockTwits | View ABIO Stock Mentions - PennyStockTweets | ||
View ABIO Stock Mentions - Twitter | View ABIO Investment Forum News - Investor Hub | ||
View ABIO Stock Mentions - Yahoo! Message Board | View ABIO Stock Mentions - Seeking Alpha |
View Insider Transactions for ABIO - SECform4.com | View Insider Transactions for ABIO - Insider Cow | ||
View ABIO Major Holdings Summary - CNBC | View Insider Disclosure for ABIO - OTC Markets | ||
View Insider Transactions for ABIO - Yahoo! Finance | View Institutional Holdings for ABIO - NASDAQ |
View ABIO Stock Insight & Charts - FinViz.com | View ABIO Investment Charts - StockCharts.com | ||
View ABIO Stock Overview & Charts - BarChart | View ABIO User Generated Charts - Trading View |
Small-Cap ARCA Biopharma Stock Soars On Merger Pact: The Details
Posted on Wednesday April 03, 2024
ARCA Biopharma Inc (NASDAQ:ABIO) and Oruka Therapeutics have entered into a definitive agreement to combine the companies in an all-stock transaction. Oruka Therapeutics is a privately held biotechnology company developing novel biologics for chronic skin diseases, including plaque psoriasis. The resulting entity will focus on advancing Oruka’s pipeline, including ORKA-001 (an IL-23p19 inhibitor) and ORKA-002 (an IL-17A/F inhibitor). Upon completion of the merger, the combined company plans to o
ARCA biopharma and Oruka Therapeutics Announce Merger Agreement
Posted on Wednesday April 03, 2024
Merger to create a company focused on advancing Oruka’s portfolio of novel biologics that aim to redefine the standard of care for patients with chronic skin diseases Oruka, the third company founded based on assets generated by Paragon Therapeutics, expects to advance ORKA-001 and ORKA-002, potentially best-in-class antibodies targeting IL-23p19 and IL-17A/F, respectively, into clinical trials in 2025 Pre-closing private financing of approximately $275 million anticipated to fund operations thr
ARCA biopharma Announces 2023 Financial Results
Posted on Thursday February 01, 2024
Company is currently engaged in a strategic review process, evaluating additional development of its assets, collaborations and other strategic options WESTMINSTER, Colo., Feb. 01, 2024 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies for cardiovascular diseases, today reported 2023 financial results and provided a corporate update. In April 2022, the Board of Directors establi
We're Not Very Worried About ARCA biopharma's (NASDAQ:ABIO) Cash Burn Rate
Posted on Wednesday December 20, 2023
Just because a business does not make any money, does not mean that the stock will go down. For example, although...